As a Senior Project Officer at EDCTP, Dr Jean Marie Vianney Habarugira manages Calls for Proposals and EDCTP-funded grants. He is responsible for the EDCTP Emerging diseases portfolio, including the COVID-19 emergency funding mechanism and other large-scale projects on epidemic preparedness.
Born and raised in Burundi, Jean Marie Vianney obtained his Master of Science in Pharmacy at the Volgograd State Medical University (Russia) in 2006. He later obtained a Bachelor’s degree in Business Administration at the NHL University in Leeuwarden (The Netherlands) before continuing his life sciences research at the Utrecht University, in a Drug Innovation Master’s programme with a focus on Drug Discovery, Drug Development and Regulatory Affairs. He carried out research projects for the KNCV Tuberculosis Foundation exploring measures for TB infection control among healthcare workers, for the Dutch Medicines Evaluation Board where he explored external validity of results from oncology clinical trials. In 2009-2010, prior to joining the EDCTP Calls and Grants Department, he carried out an EDCTP activities mapping project that served as a rolling inventory of Africa-Europe collaborations in clinical research taking place in Sub-Saharan Africa.
After joining the EDCTP Secretariat in 2010, he continued pursuing his professional development and academic interests, completing a Master’s in Pharmacovigilance and Pharmacoepidemiology at the European Programme in Pharmacovigilance and Pharmacoepidemiology (Eu2P), where he focussed on safety reporting from clinical trials conducted in resource-limited settings, specifically in Sub-Saharan Africa.
In recent years, Jean Marie Vianney was also a doctoral researcher at the Department of Pharmacology, Toxicology and Therapeutics of the Autonomous University of Barcelona (UAB), Spain, where he obtained his PhD in Pharmacology. His doctoral research project resulted in specific innovative strategies to tackle antimicrobial resistance, especially addressing the antimicrobial resistance data gap in low- and middle-income countries, using Pharmacovigilance data and networks.
He is a member of various international professional bodies, and regularly performs peer reviews for scientific journals in the areas of medicines safety, antimicrobial resistance, and epidemic preparedness.